Welcome to the multiple myeloma cilta-cel hub

Welcome to the cilta-cel hub! Cilta-cel is short for ciltacabtagene autoleucel and is the name of Janssen’s CAR-T therapy for the treatment of multiple myeloma. You may also hear cilta-cel referred to by its brand name, CARVYKTI.
Whether you’re visiting this site because you have been prescribed with cilta-cel, or you’re the caregiver to someone who has been, we hope we can provide you with useful treatment information, resources and support.
Within this site you will find several downloadable resources to help you better understand cilta-cel and prepare you for your treatment journey.
There are a few different kinds of resources that may be useful for you, depending on what kind of information you’re looking for:
Logo Janssen | Pharmaceutical Companies of Johnson & Johnson